Open Insider Trading Activity for Akcea Therapeutics, Inc. Chief Commercial Officer Jenne Kyle
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting AKCA | 2020-09-24 | 2020-09-22 | Akcea Therapeutics, Inc. | Jenne Kyle | Chief Commercial Officer | Sell | 1 | 720 | $18.12 | $13,046.40 | 1.37% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting AKCA | 2020-03-25 | 2020-03-23 | Akcea Therapeutics, Inc. | Jenne Kyle | Chief Commercial Officer | Sell | 1 | 779 | $11.75 | $9,153.25 | 1.46% | View Filing |